Questions: Cellular Adaptation: Atrophy and Metaplasia

Question 1

A patient is immobilized for 8 weeks following a hip fracture. Imaging shows the thigh muscles have significantly less mass, but the muscle cells are still alive and functional. This is best described as:

• A. Metaplasia — the muscle cells have converted to a more appropriate cell type for an inactive limb
• B. Atrophy — reduced mechanical loading and neural stimulation caused decreased protein synthesis and cell shrinkage via the ubiquitin-proteasome pathway
• C. Necrosis — insufficient blood supply killed many cells, reducing overall tissue mass
• D. Hyperplasia — muscle cells initially proliferated, then were replaced by fat cells

Answer: (B)

Atrophy is a reduction in cell *size* (not number) driven by reduced protein synthesis and/or increased proteasomal degradation. Disuse atrophy from immobilization is the canonical example: without mechanical loading and neural stimulation, muscle fibers downregulate their protein synthesis machinery, reducing cell size and organ mass while the cells remain viable. Metaplasia would involve the muscle cells *changing identity* to become a different cell type — that is not happening here. Necrosis involves cell death, which contradicts the stem indicating the cells are still alive.

Question 2

A chronic smoker's bronchial epithelium changes from its normal pseudostratified columnar ciliated type to stratified squamous epithelium. This adaptation protects against chemical irritation but eliminates mucociliary clearance. This is an example of:

• A. Atrophy — the columnar cells have shrunk under the stress of smoke exposure
• B. Metaplasia — a new, more irritant-resistant cell type has replaced the original through reprogramming of progenitor cells
• C. Hyperplasia — the epithelium has proliferated additional cell layers in response to irritation
• D. Dysplasia — the cells have become disordered and are on the path to malignancy

Answer: (B)

Squamous metaplasia is the textbook example of stress-induced cellular adaptation. The normal respiratory epithelium trades its mucus-clearing function (lost with ciliated cells) for resistance to chemical irritation (gained with squamous epithelium). This is not atrophy (cell size is not the change) and not dysplasia (the cells are well-differentiated and orderly, just of the wrong type). Critically, metaplasia occurs through reprogramming of stem/progenitor cells, not by direct transformation of mature columnar cells into squamous cells.

Question 3

Metaplasia occurs when mature, differentiated cells directly transform their identity in response to persistent stress.

• T. True
• F. False

Answer: False

Metaplasia does not involve direct cell-to-cell transformation of mature cells. Instead, it occurs through the reprogramming of stem or progenitor cells in the tissue, which then differentiate along the alternative pathway. The mature columnar cells in the bronchus do not individually convert to squamous cells; rather, as cells turn over, the stem cells that replace them produce squamous cells instead. This distinction matters clinically: it means metaplasia requires time to develop (multiple cell cycles) and reverses gradually when the stimulus is removed — it is not an immediate transformation.

Question 4

Long-standing metaplasia significantly increases the risk of progression to dysplasia and carcinoma.

• T. True
• F. False

Answer: True

While metaplastic cells are themselves well-differentiated and not cancerous, they represent a population that has already activated reprogramming pathways and acquired altered gene expression. Continued chronic irritation on a metaplastic background significantly elevates cancer risk. Barrett's esophagus (intestinal metaplasia of the lower esophagus) carries a 30-fold elevated risk of esophageal adenocarcinoma. Squamous metaplasia from smoking is a precursor to squamous cell lung carcinoma. Intestinal metaplasia from H. pylori gastritis precedes gastric cancer. This is why surveillance is warranted — catching the metaplasia-to-dysplasia transition is the clinical opportunity to intervene.

Question 5

What is the fundamental difference between atrophy and metaplasia as cellular adaptation strategies, and why does only metaplasia predispose to cancer?

Model answer: Atrophy is a change in cell *size* — the same cell type downsizes by reducing protein synthesis and increasing protein degradation to match reduced workload, without altering its identity or gene expression program. Metaplasia is a change in cell *identity* — stem cells are reprogrammed to produce an entirely different cell type better suited to the persistent stress. Metaplasia predisposes to cancer because it involves activating reprogramming pathways and altering the normal differentiation program; continued irritation on this altered progenitor background can accumulate further mutations leading to dysplasia and carcinoma. Atrophic cells have the same gene expression program as before (just less active), so they do not carry the same risk of malignant progression.

The distinction maps onto mechanism: atrophy is a quantitative adjustment (less of the same), while metaplasia is a qualitative change (different type). The clinical risk follows from the mechanism — reprogramming progenitor cells is a far larger perturbation to normal biology than simply downregulating protein synthesis. Once progenitor reprogramming pathways are active and the tissue architecture is altered, additional genetic or epigenetic hits can more easily push cells toward uncontrolled proliferation.